Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
113 Cards in this Set
- Front
- Back
barbiturates
|
phenobarbital
pentobarbital methohexital thiopental thiamylal |
|
alpha-2 agonists
|
xylazine
medetomidine detomidine |
|
benzodiazepines
|
diazepam
clonazepam zolazepam midazolam |
|
dissociative anesthetics
|
ketamine
tiletamine |
|
neuroleptics
|
phenothiazines: acepromazine, chlorpromazine
butyrophenones: droperidol |
|
pure opioid agonists
|
morphine
hydromorphone (oxymorphone) etorphine codeine dextromethorphan methadone carfentanil sufentanil fentanyl |
|
pure opioid antagonists
|
naloxone
naltrexone diprenorphine |
|
mixed opioid agonists/antagonists
|
butorphanol
buprenorphine |
|
miscellaneous opioids
|
loperamide
apomorphine |
|
inhalational anesthesetics
|
halothane
isoflurane sevoflurane nitrous oxide |
|
analeptics
|
doxapram
strychnine theophylline aminophylline theobromine |
|
local anesthetics
|
esters: cocaine, proparacaine
amides: lidocaine, bupivacaine, mepivacaine |
|
anticonvulsants
|
phenobarbital
primidone diazepam clonazepam potassium bromide felbamate gabapentin |
|
phenobarbital
|
barbiturate
used to tx seizure disorders in dogs & cats; occasionally used as oral sedative |
|
pentobarbital
|
barbiturate
sedative agent, drug of choice for tx of intractable seizures in dogs & cats d/t convulsant agents (ex. strychnine poisoning) or CNS toxins (ex. tetanus), major active ingredient in several euthanasia solutions largely replaced by ultra-short acting barbiturates b/c of slow induction, long duration of action, inactivated primarily by metabolism (don't use w/ liver dz) |
|
thiopental
|
barbiturate
ultra short acting excellent IV induction agent in young, healthy animals, or alone for very short procedures |
|
thiamylal
|
barbiturate
ultra short acting no longer available in US; replaced by thiopental |
|
methohexital
|
barbiturate
ultra-short acting anesthetic agent often used in sight hounds b/c it does not depend on redistribution to fat to reverse effect |
|
etomidate
|
ultrashort acting, hypnotic non-barbiturate induction agent
excellent induction agent for patients w/ CV, respiratory, or liver dz safe for use in sighthounds depresses cortisol production can't use in horses (excitement) |
|
propofol: facts + pros
|
non-barbiturate sedative-hypnotic agent
used for induction &/or maintenance of anesthesia, to produce prolonged sedation of patients in ICU pros: rapidly metabolized & redistributed --> very rapid recovery does NOT accumulate in body w/ chronic dosing |
|
barbiturates & lipid solubility
|
thiobarbiturate always more lipid soluble than oxybarbiturate
phenobarb<pentobarb<thiopental as lipid solubility increases: 1. duration of action decreases 2. quicker onset 3. increased rate of distribution, metabolism 4. more hypnotic potency 5. more protein binding |
|
barbiturates: metabolism & redistribution
|
renal excretion: if highly lipid soluble, completely reabsorbed --> metabolized in liver (caution w/ liver dz)
redistribution occurs if drug given rapidly (ex. IV), highly lipid soluble: drug goes to high flow organs 1st, then rapid reversal to muscle, adipose |
|
clinical uses of barbiturates
|
induction
tx of seizures to decrease ICP & tx cerebral edema euthanasia |
|
cons of barbiturates
|
NOT analgesic (HYPERalgesic at subanesthetic doses)
contraindicated w/ liver dz d/t metabolism, inc. free drug if hypoproteinemia is present can't use thiobarbiturates in sighthounds induce liver microsomal enzymes --> incr. metabolism of other drugs (phenobarb most potent) given only IV or PO w/ multiple dosing --> longer duration no pharmalogical antagonist (phenobarb OD: give bicarb to alkaline urine --> increased rate of excretion of parent drug) |
|
CV, resp. effects of barbiturates
|
brief hypotension, reflex tachycardia
transient resp. depression (+/- apnea) arrhythmias, esp. in excited animals |
|
clinical uses of alpha-2 agonists
|
preanesthetic agent
chemical restraint selectivity: xylazine < detomidine < medetomidine duration: detomidine longest |
|
effects of alpha-2 agonists
|
increases potency of other anasthetic drugs
sedation/hypnosis analgesia muscle relaxation |
|
adverse effects of alpha-2 agonists
|
emesis
resp. depression CV effects (vary b'twn drugs) bloat hyperglycemia increased urine output don't use xylazine during last mo. of pregnancy |
|
CV effects of xylazine
|
transient hypertension followed by prolonged hypotension
bradycardia arrhythmias |
|
clinical uses of guaifenesin
|
adjunct to anesthesia in horses (IV)
|
|
effects of guaifenesin
|
sedation/hypnosis
analgesia muscle relaxation antipyretic antitussive |
|
pros & cons of guifenesin
|
pros: inc. potency of barbiturates
dec. hypertonicity assoc. w/ ketamine little cardiopulmonary depression cons: not very H2O soluble --> large vols. required may hemolyze RBCs (esp. in cattle) |
|
clinical uses of benzodiazepines
|
pre-anesthetic med (often w/ opioids)
tx of seizures (midazolam: neonatal seizures in foals) tx anorexia in cats tx fears & phobias |
|
pros of benzodiazepines
|
dec. dose of other anesthetic drugs
muscle relaxant weak resp. depression minor CV effects |
|
cons of benzodiazepines
|
cannot give IM (except midazolam)
weaker sedative/hypnotic effects than other meds amnesia can't give oral diazepam to cats --> idiopathic hepatic necrosis avoid ending chronic tx abruptly tolerance w/ chronic use IV midazolam in cats --> profound tachycardia |
|
pharmacokinetics of benzodiazepines
|
lipid soluble --> extensive redistribution when given IV
metabolism: oxidative pathway --> many active metabolites reductive path --> inactive compounds midazolam: short duration d/t rapid metab & distribution |
|
mechanism of action of benzodiazpines
|
facilitates GABA by binding to site on GABA receptor --> inc. affinity of GABA for receptor & vice versa --> GABA produces inc. in chloride conductance
|
|
flumazenil
|
benzodiazepine receptor antagonist
useful in sick animals, esp. cats, to speed up recovery from anesthesia |
|
mechanism of action of barbiturates
|
low doses: facilitates GABA by binding to site on GABA receptor (separate site from benzos)
higher doses (anesthetic): decreases presynaptic release of NTs blocks postsynaptic action of excitatory NTs GABA-mimetic effect |
|
dissociative anesthetic state
|
eyes open
involuntary movements vocalization hallucinations feel separated from body |
|
physiological effects of dissociatives
|
analgesia (mostly somatic, less visceral)
sympathetic activation hypertonicity (use w/ benzos, alpha-2s, or guaifenesin) inc. ICP, IOP convulsions (use w/ benzos) apneustic breathing retention of near normal pharyngeal & laryngeal reflexes |
|
mechanism of acation of dissociatives
|
noncompetitive antagonists of NMDA glutamate receptor --> inc. activity of layer V pyramidal output neurons (that release glutamate) --> disruption of thalamic & cerebral functions
|
|
tiletamine
|
similar to ketamine, but longer duration of action
can only be bought mixed w/ benzo zolazepam = Telazol (recoveries may be prolonged & rough) |
|
clinical uses of neuroleptics
|
chemical restraint
preanesthetic meds (dec. dose of other meds) antiemetic |
|
neuroleptic syndrome
|
sedation
tranquilization dec. emotional behavior dec. responsiveness to external stimuli dec. spontaneous movement NOT hypnotic NO analgesia alone |
|
adverse effects of neurolpetics
|
extrapyramidal effects: dyskinesia, dystonia, muscle tremors
higher doses --> catalepsy hypotension hypothermia mild neg. inotropic effect dec. seizure threshold weak resp. depression, but can inc. resp. depression w/ other drugs |
|
mechanism of action of neuroleptics
|
antagonize dopaminergic, alpha-adrenergic, muscarinic, H1, certain serotonergic receptors
|
|
phenothiazine neuroleptics: effects in horses
|
ace, chlorpromazine
can cause violent incoordination & excitement penile prolapse & priapism |
|
droperidol
|
butyrophenone neuroleptic
used in various preps in SA, swine don't use in horses d/t bizarre rxns shorter duration than phenothiazine neuroleptics potent dopamine receptor antagonists --> more likely to produce extrapyramidal effects |
|
mechanism of action of opioids & opiopeptins
|
decrease release of substance P --> dec. transmission of nociceptive info
|
|
species dependent effects of morphine
|
dogs, monkey, man: analgesia, sedation, euphoria, pupillary miosis
horses, cats, pigs, ruminants: analgesia, excitement, dysphoria, mydriasis (use low doses) |
|
pros of morphine
|
valuable premed b/c dec. amt. of other drugs
antitussive mild hypotension, bradycardia |
|
cons of morphine
|
dose dependent resp. depression: CAUTION w/ lung dz, neonates
constipation, esp. w/ chronic use emetic SEVERE hypotension if in shock or w/ volume depletion |
|
hydromorphone
|
pure opioid agonist
similar to morphine, but 5x more potent less GI upset & vomiting than morphine in dogs |
|
etorphine
|
pure opioid agonist
agonist at all receptors, 1000x more potent than morphine used only to immobilize wild animals |
|
codeine
|
pure opioid agonist
10x weaker than morphine protected from 1st pass metabolism in liver --> converted to morphine uses: antitussive w/ acetaminophen to relieve pain in dogs |
|
dextromethorphan
|
pure opioid agonist
devoid of all opioid properties except ANTITUSSIVE effect |
|
meperidine
|
pure opioid agonist (=Demerol)
effective analgesic, maintains much of potency when given PO less constipating than morphine |
|
methadone
|
pure opioid agonist
accumulates in body --> inc. duration of action w/ multiple doses retains most analgesic potency when given orally tolerance, dependence develop slowly also NMBA glutamate antagonist --> dec. opioid dependence |
|
carfentanil
|
pure opioid agonist
most potent of fentanil family (all are short acting, w/ rapid onset) used to immobilize wild animals |
|
sufentanil
|
pure opioid agonist
anesthetic adjunct in dogs |
|
fentanyl
|
pure opioid agonist
anesthetic adjunct in dogs patches: control of chronic pain (absorption can be unreliable) |
|
naloxone
|
pure opioid antagonist
most commonly used opioid antagonist in vet med parenteral use only (usually IV), slightly shorter acting than morphine |
|
diprenorphine
|
pure opioid antagonist
parenteral only (usually IM) used only to reverse etorphine-induced immobilization |
|
naltrexone
|
pure opioid antagonist
uses: control crib biting in horses reverse carfentanil-induced immobilization long duration of action oral or parenteral use |
|
butorphanol
|
mixed opioid agonist/antagonist
uses: analgesic antitussive preanesthetic med chemical restraint (w/ alpha-2 agonist) popular in horses d/t low incidence of excitatory effects weak resp. depression, less constipation |
|
buprenorphine
|
mixed opioid agonist/antagonist
uses: analgesic in dogs & cats alternative to methadone for addicts longer duration of action than torb, morphine reverse w/ naloxone given PRIOR to buprenorphine well tolerated in horses |
|
loperamide
|
misc. opioid agent (=Immodium)
used to tx diarrhea avoid repeated use --> constipation can cause profound sedation in certain dog breeds (collies, Australian shepherds, etc.) |
|
apomorphine
|
misc. opioid agents
strong dopaminergic agonist emetic of choice in dogs give conjunctivally (or SQ) |
|
innovar
|
neuroleptanalgesic
= droperidol + fentanyl |
|
midazolam + morphine
|
benzo/opioid combo
given IM as pre-med to dogs that can't be handled easily &/or are in pain often given to cats as alternative to ketamine (ex. w/ intracranial mass, etc.) |
|
diazepam + morphine
|
benzo/opioid combo
given IV as pre-med to calm depressed &/or sick dogs |
|
neuroleptanalgesia
|
(+): sedation, dec. anxiety, intense analgesia, dec. movement, NO emesis, dec. dose of other drugs
(-): resp. depression, extrapyramidal effects, chest rigidity, change in autonomic fn |
|
benzodiazepine/opioid combos
|
(+): sedation, dec. anxiety, intense analgesia, amnesia, minimal autonomic effects, NO extrapyramidal effects
(-): resp. depression (easily reversed w/ opioid antagonist) |
|
determinants of tension of gas in alveoli (FA)
|
rate of delivery of gas TO alveoli:
1. tension of anesthetic gas in inspired gas (FI) 2. minute volume rate of removal of gas FROM alveoli: 1. cardiac output 2. blood solubility (Fblood)* |
|
blood solubility & induction/recovery
|
LOW blood solubility:
fast induction & recovery HIGH blood solubility: slow induction & recovery |
|
effects of inhalational anesthetics
|
all produce dose dependent depression of respiration & MAP
minimal skeletal muscle relaxation halothane is most potent (lowest MAC) sevo has fastest induction/recovery (lowest max vapor conc.) |
|
cons of halothane
|
hypotension d/t dec. myocardial contractility
arrhythmias significant hepatic biotransformation (hepatotoxic metabolites) alters Ca++ movements 1. intearctions w/ aminoglycoside Abs, Ca channel blockers --> severe CV depression 2. can produce malignant hyperthermia (esp. in pigs), caused by failure of Ca uptake in SR |
|
dantrolene sodium
|
used to tx malignant hyperthermia
decreases Ca++ release from SR |
|
sevoflurane
|
hypotension d/t vasodilation, esp. in muscle & skin (same w/ iso)
unstable in soda lime excellent for sea turtles expensive |
|
nitrous oxide
|
used as adjunct to anesthesia in small animals b/c:
1. concentration & 2nd gas effects 2. decreases dose of primary anesthetic 3. mild stimulation of symp. nervous system 4. ANALGESIC avoid conc. > 70-75% do not give to patients w/ any condition where air is trapped in viscera --> will cause air pocket to expand (ex. pneumothorax) |
|
concentration effect
|
only seen w/ high conc. of nitrous oxide
when higher conc. of anesthetic gas is inhaled, FA (& therefore Fblood), inc. at a slightly greater rate than if a lesser conc. were inhaled |
|
2nd gas effect
|
occurs when a 2nd gas (ex. 1% halothane) is inspired w/ 75% nitrous & 24% O2
conc. effect produced by 75% N2O not only concentrates O2, but also halothane --> inc. rate of movement of halothane from alveolar air to pulm. blood --> faster induction |
|
uses of analeptics
|
used to reverse drug-induced CNS depression (esp. respiratory depression)
cause general CNS stimulation --> can result in convulsions |
|
doxapram
|
most commonly used analeptic
used to stimulate respiration during or after gen. anesthesia, in newborns, in cases of cardiopulm. arrest stimulates carotid & aortic chemoreceptors --> reflux stimulation of medullary resp. centers short duration: 5-10 m. excessive doses --> hypertension, hyperventilation, seizures (rare) |
|
strychnine
|
analeptic; used as a pesticide
glycine receptor antagonist --> CNS stimulation strychnine poisoning --> severe & extremely painful convulsions |
|
theophylline
|
methylxanthine (weak analpetic)
used in tx of asthma, adjunct to digoxin to tx CHF (dilates coronary aa.) |
|
aminophylline
|
methylxanthine (weak analpetic)
H2O sol. salt of theophylline (better oral absorption) used in tx of asthma, adjunct to digoxin to tx CHF (dilates coronary aa.) |
|
theobromine
|
methylxanthine (weak analpetic)
in chocolate |
|
cocaine
|
local anesthetic (ester)
only one to cause vasoconstriction |
|
proparacaine
|
local anesthetic (ester)
used to anesthetize cornea lasts 15-30 m. |
|
lidocaine
|
local anesthetic (amide)
most widely used local anesthetic used to tx post-op ileus in horse may cause local irritation & swelling, esp. in horse |
|
bupivacaine
|
local anesthetic (amide)
useful for post-op analgesia duration up to 8 hrs |
|
mepivacaine
|
local anesthetic (amide)
most widely used local in horses b/c it causes little swelling & edema |
|
mechanism of action of local anesthetics
|
block initiation & propagation of AP by preventing voltage-dep. inc. in Na permeability that accompanies a small inc. in mem depolarization
|
|
factors influencing sensitivity of nerves to blockade by local anesthetics
|
firing rate of nerve: resting Na channels least susceptible, then open channels, inactivated channels most susceptible
pH of body fluids & pKa of local anesthetic: uncharged mols penetrate mem, but CHARGED mols bind receptors (if pH dec. d/t inflammation --> more drug needed to block) anatomical structure of nerve: small diameter n. easier to block |
|
local anesthetics: determinants of absorption from site of administration
|
dosage
site of injection: absorbed more quickly in highly vascular area extent of tissue binding: keeps drug at site of admin --> inc. duration of action concurrent admin of vasoconstricting substances: locals are vasodilators & usually sold w/ vasoconstrictor (ex. epi); vasoconstriction --> inc. efficacy b/c systemic absorption is decreased d/t low blood flow |
|
metabolism of local anesthetics
|
esters: shorter half life d/t rapid hydrolysis by plasma & liver cholinesterases
amides: hydrolyzed by liver microsomal enzymes (DO NOT USE w/ liver dz) |
|
systemic effects of cocaine
|
restlessness, euphoria --> tremors --> convulsions
vasoconstriction, hypertension, arrhythmias |
|
systemic effects of local anesthetics (except cocaine)
|
only w/ HIGH plasma levels:
marked hypotension d/t dec. cardiac contractility --> dec. CO & vasodilation by dec. symp. tone |
|
mechanisms of action of seizures
|
seizure focus activated, seizure discharge from focal area may synchronize w/ other neurons & propagate to surrounding areas of brain
dec. GABA activity & inc. glutamate activity important |
|
3 ways anticonvulsants inhibit seizures
|
1. dec. excessive discharge of seizure focus
2. inc. seizure threshold required for discharge 3. dec. spread of discharge to surrounding neurons most drugs work by 2 & 3 |
|
tx for chronic seizures in dogs & cats
|
Dogs:
1. phenobarb 2. phenobarb + KBr 3. KBr alone Cats: 1. phenobarb 2. benzodiazepine 3. third level drugs |
|
when to start tx for seizures
|
> 1 seizure/month
very intense seizures w/ breathing difficulties clusters of seizures |
|
pros of phenobarbital for tx of seizures
|
effective against wide spectrum of epilepsies
inexpensive relatively non-toxic easy to measure blood levels relatively little sedation |
|
cons of phenobarbital for tx of seizures
|
polyphagia --> wt. gain
PU/PD hepatotoxicity w/ chronic use: altered bone metabolism inc. metabolism of other drugs using liver microsomal enzymes blood dyscrasias inc. liver enzymes |
|
mechanism of action of phenobarb for tx seizures
|
inc. seizure threshold, dec. spread of discharge d/t facilitation of GABA, then also inhibition of glutamate
at higher doses, may dec. Ca flux across neuronal mem |
|
primidone
|
anticonvulsant (dogs only)
congener of phenobarb more expensive, more hepatotoxic, quite sedative intially it & 2 metabs all anti-convulsant |
|
benzodiazepines to tx seizures
|
orally ineffective in dogs
tolerance to anticonvulsant properties can develop over time most potent elevator of seizure threshold: facilitates GABA diazepam: used in cats that are refractory to phenobarb (don't give orally) clonazepam: not metab. by liver microsomal enzymes (no active metabolites), longer half life, doesn't cause hepatic necrosis |
|
cons of potassium bromide
|
vomiting
pancreatitis (rare) takes ~1 mo. to reach therapeutical plasma levels in emergency, would have to give large loading dose --> potentially cardiotoxic (can use sodium bromide IV instead) |
|
third level drugs used to tx seizures
|
felbamate (dogs)
gabapentin (dogs, cats) |
|
tx of status epilepticus
|
1. IV diazepam (2-3 doses if needed)
2. IV phenobarbital 3. if still seizing, IV pentobarbital to produce anesthesia (or IV propofol) if seizures result of strychnine poisoning: tx of choice is anesthetic dose of IV pentobarbital |
|
cons of propofol
|
-some pain w/ IV administration
-can damage tissue if given extravascularly -apnea common after administration -dose dependent vasodilation --> dec. MAP (do NOT use in hypotensive patients) -cats: chronic admin can cause oxidative injury to RBCs |